KIT and asthma: We used endobronchial biopsies collected as part of a clinical trial (the KIT inhibitor in asthma (KIA) study), whereby individuals with severe refractory asthma were treated for 6 months with a tyrosine kinase inhibitor23 (Fig. 6a, cohort 2).